CASMB Sends Letter to Administration Opposing Private Equity Firm’s IDR Application

September 9, 2025

EGWP marketplace medicaid Medicare

The Coalition Against Surprise Medical Billing (CASMB), which represents employer groups, unions, and health insurers, sent a letter to the Trump administration strongly opposing a recent application by a private equity firm to become a Certified Independent Dispute Resolution (IDR) Entity under the terms of the No Surprises Act.

In the letter, CASMB writes that Guidehouse Inc., which is owned by Bain Capital (a private equity firm with extensive health care investments including provider groups), “raises material concerns about conflicts of interest and the integrity of the IDR process… Allowing a Bain-owned entity to arbitrate out-of-network disputes would be tantamount to having the fox guard the hen house.” The scale of private equity-backed providers in IDR disputes underscores these concerns.

According to data from the Centers for Medicare & Medicaid Services, in the first half of 2024, 47% of all cases originated from just four private equity-backed organizations and 45% of filed cases were challenged as ineligible, highlighting the systemic manipulation of the process by these entities.

CASMB notes that allowing Guidehouse to be certified in the role of a neutral arbiter is incompatible with the intent of the No Surprises Act. The Coalition is urging the administration to reject Guidehouse’s application.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like